Results 31 to 40 of about 1,543,151 (246)

A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapy

open access: yesnpj Precision Oncology, 2022
Personalized treatment approaches for patients with limited liver metastases from colorectal cancer are critically needed. By leveraging three large, independent cohorts of patients with colorectal liver metastases (n = 336), we found that a ...
Liam F. Spurr   +14 more
doaj   +1 more source

How to Best Image Colorectal Liver Metastases

open access: yes, 2020
Purpose of Review Colorectal liver metastases affect about half of the patients with colorectal cancer and have an impact on prognosis. Resection of liver metastases, even after downstaging with chemotherapy, improves patient survival.
Zamboni, G. A.   +5 more
core   +1 more source

Treatment of colorectal liver metastases

open access: yesJournal of British Surgery, 1999
Abstract Background Surgical resection is the only potentially curative treatment for colorectal liver metastases, with 5-year survival rates approaching 40 per cent. However, at present only 20–25 per cent of such lesions are deemed resectable.
J G, Geoghegan, J, Scheele
openaire   +2 more sources

Surgery for Colorectal Liver Metastases [PDF]

open access: yesDigestive Surgery, 2013
Half of all patients with colorectal cancer develop metastatic disease. The liver is the principal site for metastases, and surgical resection is the only modality that offers the potential for long-term cure. Appropriate patient selection for surgery and improvements in perioperative care have resulted in low morbidity and mortality rates, resulting ...
S J, McNally, R W, Parks
openaire   +2 more sources

Prognosis-related Factors of Colorectal Cancer Patients with Positive PD-L1 Expression in Liver Metastases After Hepatectomy

open access: yesZhongliu Fangzhi Yanjiu, 2021
Objective To evaluate the prognosis-related factors of colorectal cancer patients with positive PD-L1 expression in liver metastases after hepatectomy. Methods We reviewed retrospectively the clinical data of 68 colorectal cancer patients with positive ...
ZHAO Zhengqiang   +3 more
doaj   +1 more source

Colorectal Liver Metastases [PDF]

open access: yes, 2019
Colorectal cancer is the most common form of cancer and the 2nd most frequentcancer related death in Europe. Up to half of patients with colorectal cancerdevelop liver metastases during their lifetime. This thesis concerns qualityimprovements in care of patients with colorectal liver metastases.
Julio Wiederkehr   +2 more
  +5 more sources

Liver metastases in patients with curatively treated colorectal cancer

open access: yesСибирский онкологический журнал, 2019
Background. The problem of the development of liver metastases in colorectal cancer patients previously treated with curative intent surgery remains little studied. Identification of significant factors affecting the occurrence of metachronous metastasis
R. I. Rasulov   +2 more
doaj   +1 more source

Updates of colorectal cancer liver metastases therapy: review on DEBIRI

open access: yesHepatic Oncology, 2020
Colorectal cancer is a worldwide public health issue, presenting an advanced stage at diagnosis in more than 20% of patients. Liver metastases are the most common metastatic sites and are not indicated for resection in 80% of cases.
Giammaria Fiorentini   +5 more
doaj   +1 more source

Evidence for Two Modes of Synergistic Induction of Apoptosis by Mapatumumab and Oxaliplatin in Combination with Hyperthermia in Human Colon Cancer Cells [PDF]

open access: yes, 2013
Colorectal cancer is the third leading cause of cancer-related mortality in the world-- the main cause of death from colorectal cancer is hepatic metastases, which can be treated with isolated hepatic perfusion (IHP).
Yong J. Lee   +16 more
core   +2 more sources

Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases

open access: yes, 2023
Background The role of recurrence-free survival (RFS) as a valid surrogate endpoint for overall survival (OS) in patients who underwent upfront surgery for colorectal liver metastases remains uncertain.
Takeuchi, J   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy